499

Compound name
Pirtobrutinib
Compound Image
Pirtobrutinib.png
SMILES
CC(C(F)(F)F)N1C(=C(C(=N1)C2=CC=C(C=C2)CNC(=O)C3=C(C=CC(=C3)F)OC)C(=O)N)N
MW
479.40
Brutto
C22H21F4N5O3
InChI
InChI=1S/C22H21F4N5O3/c1-11(22(24,25)26)31-19(27)17(20(28)32)18(30-31)13-5-3-12(4-6-13)10-29-21(33)15-9-14(23)7-8-16(15)34-2/h3-9,11H,10,27H2,1-2H3,(H2,28,32)(H,29,33)/t11-/m0/s1
InChI Key
FWZAWAUZXYCBKZ-NSHDSACASA-N
Approval Jurisdiction
2023 FDA
Approved for clinical use
Mantle Cell Lymphoma
CAS
2101700-15-4
PubChem CID
129269915
Approved Drug List
1